Trials / Recruiting
RecruitingNCT06780475
Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma
Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Merkel Cell Carcinoma of Skin
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to test and validate in vitro a cell therapy approach for MCPyV+ Merkel Cell Carcinoma patients.
Detailed description
The aim of the study is to test and validate in vitro a cell therapy approach for MCPyV+ Merkel Cell Carcinoma patients.
Conditions
Timeline
- Start date
- 2025-05-27
- Primary completion
- 2027-05-01
- Completion
- 2027-05-01
- First posted
- 2025-01-17
- Last updated
- 2025-11-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06780475. Inclusion in this directory is not an endorsement.